GSK3B and early-onset autosomal dominant Alzheimer disease: This widespread activity has also led to identifying GSK-3β dysregulation as responsible for the development of many diseases, such as Alzheimer’s disease (AD), bipolar disorder, diabetes, cardiovascular diseases, and cancer [7].